[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342078-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342078-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","age-associated-contraction-of-tumor-specific-t-cells-impairs-antitumor-immunity","Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity","","Progressive decline of adaptive immunity with age coincides with increasing cancer incidence. This study examines whether weakened antitumor immunity in advanced age promotes tumor progression and/or resistance to immunotherapy. Results show faster growth of multiple syngeneic cancers in aged versus young adult mice driven by dysfunctional CD8+ T cells. Mapping tumor immune-cell profiles identifies loss of tumor-antigen–specific CD8+ T cells as a key driver, with young antigen-specific T cells delaying outgrowth and restoring sensitivity to PD-1 blockade.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/age-associated-contraction-of-tumor-specific-t-cells-impairs-antitumor-immunity/342078/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/age-associated-contraction-of-tumor-specific-t-cells-impairs-antitumor-immunity/342078.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central question of the study?","Question",{"text":63,"@type":64},"Whether age-associated deficits in antitumor immunity promote tumor progression and/or drive resistance to immunotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What key mechanism links aging to worse cancer outcomes?",{"text":68,"@type":64},"Dysfunctional CD8+ T-cell responses, including loss of tumor-antigen–specific CD8+ T cells, which accelerates tumor growth in aged mice.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the researchers test antigen-specific T-cell effects across ages?",{"text":72,"@type":64},"They administer antigen-specific T cells from young adult mice to aged mice, delaying tumor outgrowth and making aged animals sensitive to PD-1 blockade.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342078,1790512505,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity  \nPeter Georgiev1,2,3, SeongJun Han1,2,3, Amy Y. Huang1,3,4, Thao H. Nguyen1,3, Jefte M. Drijvers1,2,3, Hannah Creasey1,3, Joseph A. Pereira1,3, Cong-Hui Yao2,3, Joon Seok Park1,3, Thomas S. Conway1,3, Megan E. Fung1,3, Dan Liang1,3, Michael Peluso1,3, Shakchhi Joshi2,3, Jared H. Rowe1,2,3,5,  \nBrian C. Miller6,7,8,9, Gordon J. Freeman10, Arlene H. Sharpe1,3, Marcia C. Haigis2,3, and Alison E. Ringel11,12,13  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Progressive decline of the adaptive immune system with increasing\u003Cbr>age coincides with a sharp increase in cancer incidence. In this study,\u003Cbr>we set out to understand whether deficits in antitumor immunity\u003Cbr>with advanced age promote tumor progression and/or drive resis\u003Cbr>tance to immunotherapy. We found that multiple syngeneic cancers\u003Cbr>grew more rapidly in aged versus young adult mice, driven by dys\u003Cbr>functional CD8+ T-cell responses. By systematically mapping immune\u003Cbr>cell profiles within tumors, we identified loss of tumor antigen–\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | specific CD8+ T cells as a primary feature accelerating the growth of\u003Cbr>tumors in aged mice and driving resistance to immunotherapy. When\u003Cbr>antigen-specific T cells from young adult mice were administered to\u003Cbr>aged mice, tumor outgrowth was delayed and the aged animals be\u003Cbr>came sensitive to PD-1 blockade. These studies reveal how age\u003Cbr>associated CD8+ T-cell dysfunction may license tumorigenesis in el\u003Cbr>derly patients and have important implications for the use of aged\u003Cbr>mice as preclinical models of aging and cancer. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nAging is a complex physiological process, involving molecular, cellular, and systemic changes that increase susceptibility to disease and diminish resilience under stress (1, 2) . Alterations in the  \n1Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. 2Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. 3Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 4Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. 5Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 6Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 7Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 8Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 9Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 10Dep","cbCaijXMuiaJj8Vj","https://ap.wps.com/l/cbCaijXMuiaJj8Vj","pdf",6040608,17,"English","# Introduction\n## Aging and immune decline\n## Role of CD8+ T cells in antitumor immunity","[{\"question\":\"What is the central question of the study?\",\"answer\":\"Whether age-associated deficits in antitumor immunity promote tumor progression and/or drive resistance to immunotherapy.\"},{\"question\":\"What key mechanism links aging to worse cancer outcomes?\",\"answer\":\"Dysfunctional CD8+ T-cell responses, including loss of tumor-antigen–specific CD8+ T cells, which accelerates tumor growth in aged mice.\"},{\"question\":\"How do the researchers test antigen-specific T-cell effects across ages?\",\"answer\":\"They administer antigen-specific T cells from young adult mice to aged mice, delaying tumor outgrowth and making aged animals sensitive to PD-1 blockade.\"}]","Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity | PDF",1790045080,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fd6ecf9594a4cf300033ccbc87ef25c.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/949d73fb2d3bd45a65b1fd6057916aae.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/159c7bbf987ca9e7722db3a81e191733.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56868050a74986de40b5c5479427ce0f.webp",980,1311]